» Articles » PMID: 30650355

Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting

Abstract

The tumor microenvironment plays a critical role in tumor growth, progression, and therapeutic resistance, but interrogating the role of specific tumor-stromal interactions on tumorigenic phenotypes is challenging within in vivo tissues. Here, we tested whether three-dimensional (3D) bioprinting could improve in vitro models by incorporating multiple cell types into scaffold-free tumor tissues with defined architecture. We generated tumor tissues from distinct subtypes of breast or pancreatic cancer in relevant microenvironments and demonstrate that this technique can model patient-specific tumors by using primary patient tissue. We assess intrinsic, extrinsic, and spatial tumorigenic phenotypes in bioprinted tissues and find that cellular proliferation, extracellular matrix deposition, and cellular migration are altered in response to extrinsic signals or therapies. Together, this work demonstrates that multi-cell-type bioprinted tissues can recapitulate aspects of in vivo neoplastic tissues and provide a manipulable system for the interrogation of multiple tumorigenic endpoints in the context of distinct tumor microenvironments.

Citing Articles

Osteosarcoma tumor microenvironment: the key for the successful development of biologically relevant 3D in vitro models.

Rodrigues J, Sarmento B, Leite Pereira C In Vitro Model. 2025; 1(1):5-27.

PMID: 39872973 PMC: 11756501. DOI: 10.1007/s44164-022-00008-x.


Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.

Feng Q, Shan X, Yau V, Cai Z, Xie S Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861125 PMC: 11769033. DOI: 10.3390/ph18010062.


3D Bioprinting in Cancer Modeling and Biomedicine: From Print Categories to Biological Applications.

Yang J, Wang L, Wu R, He Y, Zhao Y, Wang W ACS Omega. 2024; 9(44):44076-44100.

PMID: 39524656 PMC: 11541486. DOI: 10.1021/acsomega.4c06051.


Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics.

Jackson Cullison S, Flemming J, Karagoz K, Wermuth P, Mahoney M J Extracell Biol. 2024; 3(11):e70017.

PMID: 39483807 PMC: 11522837. DOI: 10.1002/jex2.70017.


Co-culture models for investigating cellular crosstalk in the glioma microenvironment.

Niu X, Zhang Y, Wang Y Cancer Pathog Ther. 2024; 2(4):219-230.

PMID: 39371093 PMC: 11447344. DOI: 10.1016/j.cpt.2023.11.002.


References
1.
Brooks M, Burness M, Wicha M . Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. Cell Stem Cell. 2015; 17(3):260-71. PMC: 4560840. DOI: 10.1016/j.stem.2015.08.014. View

2.
Jaster R . Molecular regulation of pancreatic stellate cell function. Mol Cancer. 2004; 3:26. PMC: 524499. DOI: 10.1186/1476-4598-3-26. View

3.
Mandrycky C, Wang Z, Kim K, Kim D . 3D bioprinting for engineering complex tissues. Biotechnol Adv. 2016; 34(4):422-434. PMC: 4879088. DOI: 10.1016/j.biotechadv.2015.12.011. View

4.
Aguilera K, Rivera L, Hur H, Carbon J, Toombs J, Goldstein C . Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. Cancer Res. 2013; 74(4):1032-44. PMC: 3944405. DOI: 10.1158/0008-5472.CAN-13-2800. View

5.
Delitto D, Pham K, Vlada A, Sarosi G, Thomas R, Behrns K . Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements. Am J Pathol. 2015; 185(5):1297-303. PMC: 4419203. DOI: 10.1016/j.ajpath.2015.01.016. View